AR020765A1 - HUMAN MONOCLONAL ANTIBODIES AGAINST UK114 TUMOR ANTIGEN AND LYMPHOCYTES AND HYBRIDID CELLS FOR PRODUCTION - Google Patents

HUMAN MONOCLONAL ANTIBODIES AGAINST UK114 TUMOR ANTIGEN AND LYMPHOCYTES AND HYBRIDID CELLS FOR PRODUCTION

Info

Publication number
AR020765A1
AR020765A1 ARP990105119A AR020765A1 AR 020765 A1 AR020765 A1 AR 020765A1 AR P990105119 A ARP990105119 A AR P990105119A AR 020765 A1 AR020765 A1 AR 020765A1
Authority
AR
Argentina
Prior art keywords
monoclonal antibodies
human monoclonal
tumor antigen
antibodies against
hybridid
Prior art date
Application number
Other languages
Spanish (es)
Original Assignee
Zetesis Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zetesis Spa filed Critical Zetesis Spa
Priority to ARP990105119 priority Critical patent/AR020765A1/en
Publication of AR020765A1 publication Critical patent/AR020765A1/en

Links

Abstract

Anticuerpos monoclonales humanos contra el antígeno tumoral UK114, método de preparacion y su uso para aplicaciones de diagnostico y aplicacionesterapéuticas. Células linfocíticas inmortalizadas capaces de producir los anticuerpos, e hibridomas.Human monoclonal antibodies against the tumor antigen UK114, method of preparation and its use for diagnostic and therapeutic applications. Immortalized lymphocytic cells capable of producing antibodies, and hybridomas.

ARP990105119 1999-10-08 1999-10-08 HUMAN MONOCLONAL ANTIBODIES AGAINST UK114 TUMOR ANTIGEN AND LYMPHOCYTES AND HYBRIDID CELLS FOR PRODUCTION AR020765A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ARP990105119 AR020765A1 (en) 1999-10-08 1999-10-08 HUMAN MONOCLONAL ANTIBODIES AGAINST UK114 TUMOR ANTIGEN AND LYMPHOCYTES AND HYBRIDID CELLS FOR PRODUCTION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP990105119 AR020765A1 (en) 1999-10-08 1999-10-08 HUMAN MONOCLONAL ANTIBODIES AGAINST UK114 TUMOR ANTIGEN AND LYMPHOCYTES AND HYBRIDID CELLS FOR PRODUCTION

Publications (1)

Publication Number Publication Date
AR020765A1 true AR020765A1 (en) 2002-05-29

Family

ID=45570058

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990105119 AR020765A1 (en) 1999-10-08 1999-10-08 HUMAN MONOCLONAL ANTIBODIES AGAINST UK114 TUMOR ANTIGEN AND LYMPHOCYTES AND HYBRIDID CELLS FOR PRODUCTION

Country Status (1)

Country Link
AR (1) AR020765A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110087670A (en) * 2016-12-16 2019-08-02 阿尔贝托·巴托雷利库萨尼 Stablize the novel recombinant protein UK 114 of polymer form for treating, diagnosing and preventing malignant entity and systemic tumor

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110087670A (en) * 2016-12-16 2019-08-02 阿尔贝托·巴托雷利库萨尼 Stablize the novel recombinant protein UK 114 of polymer form for treating, diagnosing and preventing malignant entity and systemic tumor

Similar Documents

Publication Publication Date Title
EA200100224A1 (en) COMBINED THERAPY OF IN-CELLULAR LYMPHOMES, PROVIDING ANTIBODY AGAINST CD20
ECSP066379A (en) ANTIBODIES RG1 AND USES OF THE SAME
ES2058083T3 (en) MONOCLONAL ANTIBODIES AGAINST THE HUMAN FACTOR OF TUMOR NECROSIS (TNF) AND ITS USE.
BR0314814A (en) Optimized variants of fc and methods for their generation
BR0207775A (en) Amphoteric liposomes Methods for loading them with active ingredients and their use
ES2115626T3 (en) HUMAN MONOCLONAL ANTIBODY SPECIFIC TO CANCER CELL MEMBRANE SURFACE ANTIGEN.
BR0309254A (en) Use of an anti-ctla-4 antibody
DE3687736T2 (en) MONOCLONAL ANTIBODIES AGAINST HUMAN BREAST CANCER, CORRESPONDING HYBRIDOME, THEIR PRODUCTION AND USE.
AR035352A1 (en) ANTI-LT-BETA-R HUMANIZED ANTIBODIES
CR10273A (en) "ANTI-5T4 ANTIBODIES AND USES OF THE SAME"
ES2150573T3 (en) COMPOSITION CONTAINING AUTOANTIBODIES FOR TUMOR THERAPY AND PROPHYLAXIS.
UY27499A1 (en) HUMAN ANTIBODIES THAT JOIN MN AND HAVE NEUTRALIZING ACTIVITY OF CELLULAR ADHESION
AR026946A1 (en) OSTEOPROTEGERINE / TUMOR NECROSIS FACTORS RECEPTORS
DE59508864D1 (en) MONOCLONAL ANTIBODY AGAINST CD44v6
WO2005055936A3 (en) Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells
DE60320009D1 (en) Transplant-accepting cells of monocytic origin, as well as their preparation and use
DE60217698D1 (en) TREATMENT OF CHRONIC RADIATION IGNITION USING AN ANTIBODY AGAINST THE CD3 ANTIGEN COMPLEX
ECSP088636A (en) ANTIGENS OF DES-N-ACETYL-SIALIC ACID, ANTIBODIES FOR THE SAME, AND METHODS OF USE IN CANCER THERAPY
ES2177509T3 (en) EMPLOYMENT OF ANTIBODIES FOR VACCINATION AGAINST CANCER.
ATE395363T1 (en) MONOCLONAL ANTIBODIES TO THE PROTEIN G3BP AND THEIR USES
ES2165506T3 (en) ANTAGONISTS OF IL-8 FOR THE TREATMENT OF ASTHMA.
ATE252374T1 (en) ENCAPSULATED ANTIBODY PRODUCING CELLS
AR020765A1 (en) HUMAN MONOCLONAL ANTIBODIES AGAINST UK114 TUMOR ANTIGEN AND LYMPHOCYTES AND HYBRIDID CELLS FOR PRODUCTION
ATE490271T1 (en) RECEPTOR, ITS USE AND MOUSE ANTIBODIES
NO20022276L (en) Placental human neurokinin B precursor

Legal Events

Date Code Title Description
FB Suspension of granting procedure